You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《瑞通窩輪》【瑞通認股證牛熊證】美團曾急挫3%失70元關 吉利250天線遇阻倒跌 恆指購19836沽19842/ 美團牛54039 最低收回價熊54382/ 舜光購12455 熊54140
阿思達克 09-10 10:35

投資者繼續憧憬美國聯儲局今月減息,以及中美下月貿易談判有進展,道指隔晚收報26835點,升38點(或0.14%),連升4日。

恆指近日橫行待變,昨收市微跌9點報26681點,今早高位升超過100點,一度重返26800點之上,惟再遇阻力,指數轉為好淡爭持,目前恆指技術阻力先觀察50天線(約27066點)的位置。恆指好倉(牛證及認購權證)昨淨流入逾1800萬港元(下同),恆指淡倉(熊證及認沽權證)同日淨流入逾2100萬元,反映投資者對後市好淡分歧。昨日恆指牛證街貨重貨區為收回價25800至25880點,而熊證街貨重貨區為收回價27000至27099點。

美團(03690)自上月下旬升抵77元的上市新高後,股價徐徐而下,昨曾跌2.5%至72元以下,連續3日處10天線之下。股份今早繼續調整,跌幅逐步擴大至超過3%,曾失守20天線約71元的位置、以及70元的心理關口,技術上回補8月26日之上升裂口。昨日有逾300萬元資金淨流入美團的好倉,淡倉同日則有12萬元淨流出。

吉利(00175)八月總銷量為近4個月以來首度單月銷量重上10萬,配合有券商預期內地整體新車銷售或於下半年復甦,帶動昨日晉身國企指數成分股的吉利,以近全日高位13.42元收市,升幅5.2%成為表現最佳藍籌。昨收市後有消息指,吉利控股與戴姆勒入股德國飛行出租車企業Volocopter。吉利控股及Volocopter將在中國成立合資公司,計劃把城市空中出行解決方案引入中國。吉利連升四個交易日、累積升逾14%後,今早曾再升逾3%,高位曾觸及250天線約13.8元,惟其後升幅大為收窄,並由升轉跌,暫可視為急升後於高位整固。昨有逾220萬元資金淨流出其好倉,淡倉同日則有76萬元淨流入。

沙特重申維持限產以保持油市平衡,紐約期油隔晚收升逾2%。中石油(00857)昨獲北水追捧,淨流入約1.62億元。股份由八月尾低見的52周低位3.69元開始逐步回升,昨曾升4.5%至4.17元高位,期間累升13%,股價重返七月下旬水平。中石油今早續升逾1%,上試4.2元,暫連升5個交易日。輪證資金流方面,昨有21萬元資金淨流出其好倉,淡倉同日則有16萬元淨流入。

早前強勢的醫藥股昨現較顯著沽壓,石藥(01093)昨倒跌2.8%收市,回落至15.5元水平,未能企穩16元和10天線。股份今早好淡爭持,大致於15.3至15.7元之間徘徊。昨分別有19萬元和91萬元淨流入其好倉和淡倉。

瑞通相關認股證之選擇:

恆指貼價、短期購19836,行使價:27600點,2019年11月到期,實際槓桿:17.4倍

恆指貼價、中短期沽19842,行使價:25400點,2019年12月到期,實際槓桿:12.2倍

美團輕微價外、中短期購20429,行使價:80元,2020年2月到期,實際槓桿:5.5倍

吉利輕微價外、短期購18351,行使價:14.9元,2019年11月到期,實際槓桿:9.6倍

中油輕微價外、中短期購20528,行使價:4.6元,2020年1月到期,實際槓桿:12.3倍

中油價內、中短期沽18350,行使價:4.18元,2020年1月到期,實際槓桿:6.4倍

石藥貼價、短期購28829,行使價:16.38元,2019年12月到期,實際槓桿:5.9倍

舜光輕微價外、短期購12455,行使價:128.8元,2019年12月到期,實際槓桿:6.7倍

騰訊輕微價外、中短期購22644,行使價:364元,2019年12月到期,實際槓桿:11倍

騰訊貼價、中短期沽20543,行使價:335.7元,2019年12月到期,實際槓桿:8.6倍

瑞通相關牛熊證之選擇:

恆指牛證54912,收回價:25710點,槓桿比率:25.4倍

恆指N類熊證52306,收回價:27280點,槓桿比率:35.6倍

美團牛證54039,收回價:63.1元,槓桿比率:5.9倍

美團市場上最低收回價的熊證54382,收回價:77.9元,槓桿比率:5.7倍

舜光熊證54140,收回價:123.9元,槓桿比率:8.4倍

騰訊牛證55002,收回價:320.1元,槓桿比率:13倍

騰訊熊證52522,收回價:353.9元,槓桿比率:19.4倍重要風險通知

本結構性產品並無抵押品。

結構性產品之價格一般可急升亦可急跌,有可能損失結構性產品之全部或重大部分購買價,閣下對此應有所準備。

閣下投資前應了解產品風險,如有需要應諮詢專業建議。~重要聲明:

以上資訊由第三方提供,AASTOCKS.com Limited對於任何包含於、經由、連結、下載或從任何與本網站有關服務所獲得之資訊、內容或廣告,不聲明或保證其內容之正確性或可靠性。對於您透過本網站上之廣告、資訊或要約而展示、購買或取得之任何產品、資訊資料,本公司亦不負品質保證之責任。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account